Risk subgroups and intervention effects among infants at high risk for peanut allergy: A model for clinical decision making.

In this study, risk subgroups were determined among infants from the LEAP trial based on the probability of developing peanut allergy and the intervention effects of early peanut introduction were estimated. This may be relevant for further risk assessment and personalized clinical decision-making.